First Trust Advisors’s Cidara Therapeutics CDTX Stock Holding History

First Trust Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-59,551	Closed	-$13.2M	–	2627
2025 Q4	$13.2M	Buy	+59,551	New	+$9.62M	0.01%	1002

First Trust Advisors's CDTX Position: Q1 2026 in Review

First Trust Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 59,551 shares — an estimated $13.2M sold.

First Trust Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $13.2M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

First Trust Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
First Trust Advisors sold 59,551 Cidara Therapeutics shares in Q1 2026, an estimated $13.2M.
First Trust Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
First Trust Advisors's Cidara Therapeutics position peaked at $13.2M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.